Use of the BrainPort® Balance Device to Improve Balance in Adults With Balance Deficits Due to Stroke

June 27, 2012 updated by: Wicab

A Substitute Vestibular Information System Using the BrainPort® Balance Device for Adults With Chronic Vestibular Dysfunction Following Stroke

The purpose of this study is to evaluate the safety and efficacy of the BrainPort balance device in improving balance in people with balance deficits due to stroke.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Following baseline assessments, subjects participate in 5 consecutive days (10 hours) of clinic training with the BrainPort balance device with a Physical Therapist. Assessments are repeated at the end of clinic training. Following clinic training, subjects take the device home to use for two (2) 20 minute training sessions each day. Subjects return to the clinic for one (1) day of testing after using the device at home for 7 weeks.

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Middleton, Wisconsin, United States, 53562
        • University of Wisconsin-Madison

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 18 years old.
  • Diagnosis of stroke for at least 6 months.
  • Reached a plateau and been discharged from physical therapy.
  • Able to ambulate with or without assistance.
  • Ongoing balance problem.
  • Able to read and understand the informed consent form, and willing to sign the informed consent form.

Exclusion Criteria:

  • Current oral health problems as determined by health questionnaire and an examination of the oral cavity.
  • Any medical condition that would interfere with performance on the assessments.
  • History of seizures.
  • Pregnancy.
  • Cognitive deficits (Mini-Mental 25 or below), joint replacements, cervical vertigo, or major neurologic disease, major depression or disabling psychiatric disorder.
  • Known neuropathies of tongue or skin tactile system.
  • Prior exposure to BrainPort® balance device.
  • Subjects who are unwilling or unable to adhere to all study requirements, including completion of the training period, evaluation tests, and return to clinic for a follow-up visit.
  • Subjects who have undergone middle ear or other surgery with sacrifice or damage to the chorda tympani nerve, lingual nerve, or hypoglossal nerve.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Dynamic Gait Index
Time Frame: baseline, 5 days, end of study
baseline, 5 days, end of study
Berg Balance Scale
Time Frame: Baseline, 5 days, end of study
Baseline, 5 days, end of study
Activities-specific Balance Confidence Scale
Time Frame: Baseline, 5 days, end of study
Baseline, 5 days, end of study
Timed Up and Go
Time Frame: Baseline, 5 days, end of study
Baseline, 5 days, end of study
Stroke Impact Scale
Time Frame: Baseline, 5 day, end of study
Baseline, 5 day, end of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mary Beth Badke, PT, PhD, University of Wisconsin, Madison

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion (Actual)

April 1, 2010

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

December 3, 2007

First Submitted That Met QC Criteria

December 3, 2007

First Posted (Estimate)

December 5, 2007

Study Record Updates

Last Update Posted (Estimate)

June 28, 2012

Last Update Submitted That Met QC Criteria

June 27, 2012

Last Verified

June 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebrovascular Accident

Clinical Trials on BrainPort Balance Device

3
Subscribe